Number of Tuberculosis Cases: California, 1930-2006

1
Number of Tuberculosis Cases California,
1930-2006
Number of Tuberculosis Cases
2
Number of Tuberculosis Cases and
Case Rates California, 1997-2006
Number of Cases
Case Rate per 100,000
Number of Cases Case Rate per 100,000 Population
3
Tuberculosis Cases by Race/Ethnicity California,
2006
American Indian/ Alaska Native 9 (0.3)
Unknown 4 (0.1)
Black 208 (7.5)
White 267 (9.6)
Asian/Pacific Islander 1,223 (44.0)
Hispanic 1,068 (38.4)
4
Tuberculosis Case Rates by Race/Ethnicity
California, 1997-2006
Asian/Pacific Islander
Cases per 100,000
Black
Hispanic
American Indian/Alaska Native
White
5
Tuberculosis Cases in Foreign-born and
U.S.-born Persons California, 1997-2006
Percent of Cases
Number of Cases
6
Tuberculosis Cases by Country of Origin
California, 2006
Unknown 13 (0.5)
U.S.-born 630 (22.7)
Foreign-born 2,136 (76.9)
67
All Others 770 (36.0)
Mexico 670 (31.4)
Vietnam 269 (12.6)
Philippines 427 (20.0)
7
Tuberculosis Cases in Persons 0-4 Years of Age
California, 1997-2006
Number of Cases
Percent of Cases
8
Tuberculosis Cases by Verification Criteria
California, 2006
Positive Smear 13 (0.5)
Provider Diagnosis 199 (7.2)
Clinical Case 326 (11.7)
Positive Culture 2,241 (80.6)
9
Deaths in Persons with Tuberculosis California,
1996-2004
Percent of Cases
Number of Deaths
10
Tuberculosis Cases by AIDS Diagnosis
California, 1995-2004
Number of Cases with AIDS
Percent of Cases with AIDS
Match found in AIDS Case Registry, California
Office of AIDS.
11
AIDS-associated Tuberculosis by Race/Ethnicity
California, 1995-2004
Hispanic
Black
White
Number of Cases with AIDS
American Indian/Alaska Native
Asian/Pacific Islander
Match found in AIDS Case Registry, California
Office of AIDS.
12
Tuberculosis Cases with Multidrug-resistance
(MDR) on Initial or Final Drug Susceptibility
Testing California, 1995-2004
58
48
47
43
42
40
39
39
35
34
Number of MDR Tuberculosis Cases
Cases with resistance to at least isoniazid and
rifampin reported on the Initial Drug
Susceptibility Report (Follow-up 1) or on the
Case Completion Report (Follow-up 2).
13
Tuberculosis Cases with Initial
Multidrug-resistance (MDR) California, 2002-2006
Initial MDR Cases 2002-2006
³ 25 Cases 15-24 Cases 5-14 Cases 1-4 Cases None
Berkeley
San Francisco
Pasadena
Long Beach
Cases with initial drug resistance to at least
isoniazid and rifampin.
14
Tuberculosis Cases1 by Outcome of Therapy in
Reporting Jurisdiction California, 2004
No Info 22 (0.8)
Lost3 49 (1.7)
Other 18 (0.6)
Died 183 (6.3)
Refused 10 (0.3)
Moved2 234 (8.1)
Completed Therapy 12 Months 2,075 (71.5)
Completed Therapy gt12 Months 313 (10.8)
1 Patient alive at diagnosis and started on an
initial drug regimen of one or more drugs. 2
Patient moved to another jurisdiction with a
known forwarding address before treatment was
completed. 3 Patient could not be located prior
to the completion of treatment.
15
Outcome in Tuberculosis Cases1 for Whom Greater
than One Year of Treatment was Indicated2
California, 2004
No Information 5 (5.6)
Refused 1 (1.1)
Lost4 4 (4.5)
Completed Therapy 12 Months 18 (20.2)
Died 10 (11.2)
Moved3 13 (14.6)
Completed Therapy gt12 Months 38 (42.7)
1Treatment in the jurisdiction reporting the
case. 2Includes cases with rifampin resistant
disease, cases with meningeal disease, and cases
less than 15 years of age with disseminated
tuberculosis disease. 3 Patient moved to another
jurisdiction with a known forwarding address
before treatment was completed. 4 Patient could
not be located prior to the completion of
treatment.
16
Outcome in Tuberculosis Cases1 for Whom Greater
than One Year of Treatment was Indicated2
California, 2004
No Information 5 (5.6)
Refused 1 (1.1)
Lost4 4 (4.5)
Completed Therapy 12 Months 18 (20.2)
Died 10 (11.2)
Moved3 13 (14.6)
Completed Therapy gt12 Months 38 (42.7)
1Treatment in the jurisdiction reporting the
case. 2Includes cases with rifampin resistant
disease, cases with meningeal disease, and cases
less than 15 years of age with disseminated
tuberculosis disease. 3 Patient moved to another
jurisdiction with a known forwarding address
before treatment was completed. 4 Patient
could not be located prior to the completion of
treatment.
17
Completion of Tuberculosis Therapy
California,1995-2004
Note Excludes cases with rifampin resistant
disease, cases with meningeal disease, cases less
than 15 years of age with disseminated
tuberculosis disease, and those that died during
treatment.